Use of BCG in the treatment of human neoplasms: a review.
D000208:Acute Disease; D000276:Adjuvants, Immunologic; D000818:Animals; D000917:Antibody Formation; D001500:BCG Vaccine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D002051:Burkitt Lymphoma / Q000628:therapy; D002908:Chronic Disease; D006168:Guinea Pigs; D006689:Hodgkin Disease / Q000628:therapy; D006801:Humans; D007938:Leukemia / Q000517:prevention & control; D007945:Leukemia, Lymphoid / Q000276:immunology / Q000628:therapy; D007951:Leukemia, Myeloid / Q000628:therapy; D015470:Leukemia, Myeloid, Acute / Q000276:immunology / Q000628:therapy; D008545:Melanoma / Q000628:therapy; D009369:Neoplasms / Q000209:etiology / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D009374:Neoplasms, Experimental; D009858:Oncogenic Viruses
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine